Leif E. Pedersen
Senior AdvisorMr. Leif E. Pedersen serves as Director at ConcertAI LLC since January 13, 2020. He served as a Senior Operating Partner at SymphonyAI Group from October 2019 to August 2020. He served as President & Chief Commercial Officer at Certara, Inc. since August 2023 until August 1, 2026, will remain with company until December 31, 2026 and was its President of Software since September 2020 until August 2023. He was Chief Executive Officer of BIOVA from September 2017 to September 2019 and Executive Vice President at Innovative Interfaces from December 2015 to August 2017. He served as Senior Vice President of Product Management, R&D and Marketing of Innovative Interfaces Inc. and served as its Chief Marketing Officer of Product Management and Marketing. Mr. Pedersen served as Senior Vice President of Marketing, Product Management and Corporate Development at Symyx Technologies Inc. Mr. Pedersen served as Senior Vice President of Marketing, Product Management and Corporate Development at Accelrys Inc., since October 1, 2012. Mr. Pedersen is a seasoned software industry executive. He has product and marketing experience with Fortune 500 Companies, as well as a track record of building high-performance teams. He was most recently CEO of Dassault Systèmes BIOVIA. He served as Vice President of Siemens with global responsibility for multiple vertical markets, including automotive, pharmaceutical, aerospace, consumer packaged goods, food and beverage and chemicals industries. Prior to Siemens' acquisition of UGS, he served as Vice President at UGS, where he managed its short- and long-term overall business strategy for eight major vertical industries. He was part of a team that successfully grew UGS into a leading global product lifecycle management (PLM) software solutions company. Prior to UGS, Mr. Pedersen held executive leadership positions with Vignette Corp., Novell Inc., Computer Associates and Oracle Corporation.
Positions
- Company NameCertara, Inc.Stock CodeCERTPositionSenior AdvisorColleagues
- RPRobert P. AspburyPresident of Model Informed Discovery & Drug Development
- JEJames E. CashmanIndependent Chairman of the Board
- AKAdrian K. McKemeyPresident of Development Strategy & Evidence
- JRJon ResnickCEO & Director
- JPJulien PerrierPresident & Chief Commercial Officer
- MMMatthew M. WalshIndependent Director
- NKNancy KilleferIndependent Director
- EBEran BroshyIndependent Director
